Search Results - "NATUK, Robert"
-
1
Development and validation of a standardized human complement serum bactericidal activity assay to measure functional antibody responses to Neisseria gonorrhoeae
Published in Vaccine (01-01-2025)“…The recent entry of multiple vaccines targeting Neisseria gonorrhoeae (Ng) into the clinical development pathway has highlighted the need to establish methods…”
Get full text
Journal Article -
2
Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models
Published in Vaccine (10-03-2014)“…Highlights • Attenuated HSV-2 is a viable approach for genital herpes vaccine development. • An UL24 mutant had reduced virulence in mouse and guinea pig…”
Get full text
Journal Article -
3
Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice
Published in Journal of Virology (01-01-2008)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
4
Synergistic Attenuation of Vesicular Stomatitis Virus by Combination of Specific G Gene Truncations and N Gene Translocations
Published in Journal of Virology (01-02-2007)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
5
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation
Published in Vaccine (14-05-2009)“…Abstract Recombinant vesicular stomatitis viruses (rVSVs) are being developed as potential HIV-1 vaccine candidates. To characterize the in vivo replication…”
Get full text
Journal Article -
6
Recombinant Vesicular Stomatitis Virus Vectors Expressing Herpes Simplex Virus Type 2 gD Elicit Robust CD4+ Th1 Immune Responses and Are Protective in Mouse and Guinea Pig Models of Vaginal Challenge
Published in Journal of Virology (01-05-2006)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
7
Herpes Simplex Virus Type 2 UL24 Gene Is a Virulence Determinant in Murine and Guinea Pig Disease Models
Published in Journal of Virology (01-08-2005)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D
Published in Vaccine (08-03-2007)“…Abstract The safety of a propagation-defective Venezuelan equine encephalitis virus (VEEV) replicon particle vaccine was examined in mice. After intracranial…”
Get full text
Journal Article -
9
Interleukin-12 redirects murine immune responses to soluble or aluminum phosphate adsorbed HSV-2 glycoprotein D towards Th1 and CD4 + CTL responses
Published in Vaccine (25-11-2004)“…The type of immune response elicited against HSV-2 infection may be a factor in the frequency and severity of recurrent disease, with non-recurrent status…”
Get full text
Journal Article -
10
Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4 + CTL epitope located at the transmembrane-cytoplasmic junction
Published in Cellular immunology (01-02-2006)“…The glycoprotein D of HSV-2 (gD2) is currently a leading candidate vaccine target for genital herpes vaccines as both cellular and humoral responses can be…”
Get full text
Journal Article -
11
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine
Published in The Journal of infectious diseases (01-07-2015)“…Background. Persons with human immunodeficiency virus (HIV) infection are at increased risk of pneumococcal disease. We evaluated the safety and immunogenicity…”
Get full text
Journal Article -
12
Induction of Neutralizing Antibodies to T-Cell Line-Adapted and Primary Human Immunodeficiency Virus Type 1 Isolates with a Prime-Boost Vaccine Regimen in Chimpanzees
Published in Journal of Virology (01-02-1998)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
13
Adenovirus-Human Immunodeficiency Virus (HIV) Envelope Recombinant Vaccines Elicit High-Titered HIV-Neutralizing Antibodies in the Dog Model
Published in Proceedings of the National Academy of Sciences - PNAS (15-08-1992)“…Recombinant human adenoviruses (Ads) (types 4, 5, and 7) expressing the HIV-1 envelope membrane glycoprotein (gp160) were tested for immunogenicity in the dog…”
Get full text
Journal Article -
14
Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration
Published in AIDS research and human retroviruses (01-11-1994)“…Recombinant adenovirus (Ad)-human immunodeficiency virus (HIV) vaccines expressing HIVIIIB Env and Gag proteins were evaluated for immunogenicity in…”
Get more information
Journal Article -
15
Blastogenesis of large granular lymphocytes in nonlymphoid organs
Published in Journal of leukocyte biology (01-06-1988)“…High numbers of large granular lymphocytes (LGL) accumulate in the livers and peritoneal cavities of mice during the course of viral infection. Accumulation of…”
Get more information
Journal Article -
16
Immunogenicity of co-administered recombinant VSV vectors expressing GM-CSF and HIV-1 Gag in mice (47.25)
Published in The Journal of immunology (1950) (01-04-2007)“…Abstract Highly attenuated recombinant vesicular stomatitis virus (rVSV) vectors expressing HIV-1 Gag have been shown to be immunogenic in preclinical animal…”
Get full text
Journal Article -
17
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization
Published in Nature medicine (01-06-1997)“…A combination AIDS vaccine approach consisting of priming with adenovirus-HIV-1MN gp160 recombinants followed by boosting with HIV-1SF2 gp120 was evaluated in…”
Get full text
Journal Article -
18
Recombinant Vesicular Stomatitis Virus Vectors Expressing Herpes Simplex Virus Type 2 gD Elicit Robust CD4 super(+) Th1 Immune Responses and Are Protective in Mouse and Guinea Pig Models of Vaginal Challenge
Published in Journal of virology (01-05-2006)“…Recombinant vesicular stomatitis virus (rVSV) vectors offer an attractive approach for the induction of robust cellular and humoral immune responses directed…”
Get full text
Journal Article -
19
Immunogenicity and Efficacy Testing in Chimpanzees of an Oral Hepatitis B Vaccine Based on Live Recombinant Adenovirus
Published in Proceedings of the National Academy of Sciences - PNAS (01-09-1989)“…As a major cause of acute and chronic liver disease as well as hepatocellular carcinoma, hepatitis B virus (HBV) continues to pose significant health problems…”
Get full text
Journal Article -
20
Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees
Published in AIDS research and human retroviruses (01-05-1993)“…Recombinant human adenovirus (Ad) type 4-, 5-, and 7-vectored vaccines expressing either the HIV env or gag-protease genes were tested for immunogenicity in…”
Get more information
Journal Article